Cornelis M. van Tilburg, MD, PhD

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany
Heidelberg, Baden-Wurttemberg, Germany

Disclosure information not submitted.

Presentation(s):

• Paper 69 - UPDATED EFFICACY, SAFETY, AND TREATMENT DISCONTINUATION OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS

  Saturday, November 16, 2024
  8:00 AM – 9:00 AM PST